(-0.08%) 5 464.77 points
(-0.06%) 39 089 points
(0.16%) 17 746 points
(-0.69%) $80.27
(-4.32%) $2.64
(-0.84%) $2 311.20
(0.01%) $28.87
(2.30%) $1 009.10
(0.30%) $0.936
(0.73%) $10.68
(0.49%) $0.792
(-0.14%) $87.37
Live Chart Being Loaded With Signals
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of central nervous system and neurobiological disorders...
Stats | |
---|---|
Today's Volume | 1 198 |
Average Volume | 0 |
Market Cap | 4.44M |
EPS | $-0.600 ( Q1 | 2024-05-08 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0100 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-29 | Silva Raul R. | Buy | 1 000 | Stock Option (right to Buy) |
2023-09-29 | Silva Raul R. | Buy | 10 000 | Stock Option (right to Buy) |
2023-09-15 | Callahan Jennifer L. | Buy | 5 000 | Common Stock |
2023-09-08 | Werth Peter J. | Buy | 6 838 235 | Pre-Funded Warrant (right to buy) |
2023-08-11 | Werth Peter J. | Buy | 1 823 155 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 79 transactions |
Buy: 10 002 264 | Sell: 8 300 |
Cingulate Inc. Correlation
10 Most Positive Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cingulate Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-582 918 (0.00 %) |
EPS: | $-26.01 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-582 918 (0.00 %) |
EPS: | $-26.01 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-621 993 (0.00 %) |
EPS: | $-31.57 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cingulate Inc.
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of central nervous system and neurobiological disorders. The company\'s lead product candidates are CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine) for the treatment of attention deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas with an additional location in Morristown, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators